The funding will increase clinical capacity and support the delivery of Phase I trials for novel medicines.
"BDD is an excellent example of an ambitious and innovative Scottish life science company with global reach. Its patented timed-release technology, alongside world-class clinical trial services offering, created a compelling proposition for the pharma industry. Building on a successful 18 months after the challenges of the pandemic, the company is well poised to pursue its growth strategy. We’re excited by what the future holds for BDD and looking forward to supporting Carol and the team."
— Sarah Hardy, Director and Head of New Investment
Creandum led the Series A round with participation from Peter Thiel, firstminute, Seedcamp, Hambro Perks and Amino Collective.
"Clinical trials are the biggest bottleneck to improving human health. We deliver clinical trials three times faster than the industry standard, working with biotech pioneers to get new treatments to patients more quickly."
The investment round was led by 24Haymarket with participation from angel investors and Innovate UK.
"We’re delighted to announce Lori as the new Chair of our Board. The wealth of her strategic experience in the digital space coupled with her sales expertise and commitment to diversity and inclusion, will support myGwork’s ambitious international growth targets,"
The investment round was led by FINTOP Capital with participation from Gresham House Ventures.
"From our first conversation, it was clear that the FINTOP team really understood the legal technology space. They are a team of former technology operators, including Rick Kushel the former CEO of DealCloud (which was acquired by Intapp in 2018). They are uniquely positioned to support us to execute on our next phase of growth, of which expansion into the US market is an important part. With the additions of Mark and Chris, we’re confident we have a highly skilled Board that is passionate about freeing lawyers from the drudgery of deal administration with streamlined legal transactions. I can’t wait to work with them through this next phase of growth."